90983-11-2

Upstream product

• 98228-82-1 Z-His-Thr(Bu^t)-Phe-Val-Lys(Boc)-OBu^t 
• 3496-11-5 2,5-dioxopyrrolidin-1-yl (2S)-2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate 
• 98228-81-0 H-Thr(Bu^t)-Phe-Val-Lys(Boc)-OBu^t*HCl 
• 98228-80-9 Z-Thr(Bu^t)-Phe-Val-Lys(Boc)-OBu^t 
• 98228-79-6 H-Phe-Val-Lys(Boc)-OBu^t*HCl 
• 98228-78-5 Z-Phe-Val-Lys(Boc)-OBu^t 
• 98228-77-4 H-Val-Lys(Boc)-OBu^t*HCl 
• 13288-57-8 1,1-dimethylethyl N₆-{[(1,1-dimethylethyl)oxy]carbonyl}-L-lysinate hydrochloride 
• 98228-76-3 Benzyloxycarbonyl-L-valyl-N^ε-t-butyloxycarbonyl-L-lysine t-butyl ester 

Downstream Products

• 90983-12-3 Nps-Cys(SBu^t)-Thr(Bu^t)-Thr(Bu^t)-Thr(Bu^t)-His-Thr(Bu^t)-Phe-Val-Lys(Boc)-OBu^t 

Relevant academic research and scientific papers

Synthesis of the Hypothetical Active Site of the Nerve Growth Factor

The synthesis of an unsymmetrical cystine peptide corresponding to the sequence 10-25/75-88 of mouse nerve growth factor was performed via the newly developed sulfenohydrazide procedure.The triacontapeptide isolated at a high degree of purity after Sephadex-LH 20 chromatography, did not exhibit in the biological assays the expected nerve growth factor activity as reported by Revoltella and coworkers. - Keywords: Nerve growth factor; Peptide synthesis; Unsymmetrical cystine peptides